RxDoctor Payments DataLook up a doctor →

ROZLYTREK: payments to doctors

Payments that named ROZLYTREK as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$839K
Providers
3,296
Transactions
7,756
Average per transaction
$108

The per-transaction average — $108 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,296 providers the average total is $255, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Genentech USA, Inc.$683,24981.4%
Genentech, Inc.$155,75618.6%
← All drugs & devices